Published in J Biol Chem on April 24, 2001
The exon junction complex is detected on CBP80-bound but not eIF4E-bound mRNA in mammalian cells: dynamics of mRNP remodeling. EMBO J (2002) 2.76
Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J Virol (2002) 2.28
Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions. Mol Cell Biol (2006) 1.71
Melanoma proliferation and chemoresistance controlled by the DEK oncogene. Cancer Res (2009) 1.61
Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivo. Cancer Res (2009) 1.47
Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK. Mol Cell Biol (2004) 1.43
DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress. Mol Cell Biol (2008) 1.40
In vivo recruitment of exon junction complex proteins to transcription sites in mammalian cell nuclei. RNA (2004) 1.35
Transcriptional activation by AP-2alpha is modulated by the oncogene DEK. Nucleic Acids Res (2003) 1.31
Functional domains of the ubiquitous chromatin protein DEK. Mol Cell Biol (2004) 1.27
The DEK nuclear autoantigen is a secreted chemotactic factor. Mol Cell Biol (2006) 1.27
Structure-specific binding of the proto-oncogene protein DEK to DNA. Nucleic Acids Res (2003) 1.24
Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29. J Virol (2008) 1.18
The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity. Genes Dev (2011) 1.17
DEK proto-oncogene expression interferes with the normal epithelial differentiation program. Am J Pathol (2008) 1.15
DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen. Arthritis Rheum (2011) 1.06
DEK binding to class II MHC Y-box sequences is gene- and allele-specific. Arthritis Res Ther (2003) 0.94
Expression and significance of tumor-related genes in HCC. World J Gastroenterol (2005) 0.93
KSHV LANA--the master regulator of KSHV latency. Viruses (2014) 0.91
High-affinity interaction of poly(ADP-ribose) and the human DEK oncoprotein depends upon chain length. Biochemistry (2010) 0.90
Protein phosphatase 2A enhances activation of human immunodeficiency virus type 1 by phorbol myristate acetate. J Virol (2003) 0.88
The possible functions of duplicated ets (GGAA) motifs located near transcription start sites of various human genes. Cell Mol Life Sci (2011) 0.86
Solution NMR structure of the N-terminal domain of the human DEK protein. Protein Sci (2008) 0.84
Concise review: role of DEK in stem/progenitor cell biology. Stem Cells (2013) 0.84
A DEK domain-containing protein modulates chromatin structure and function in Arabidopsis. Plant Cell (2014) 0.77
Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer. J Oncol (2015) 0.77
The role of mononuclear phagocytes in HTLV-III/LAV infection. Science (1986) 17.33
Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA (1986) 2.86
Acute cytomegalovirus infection complicated by vascular thrombosis: a case report. Clin Infect Dis (2001) 2.08
Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J Virol (2001) 1.80
Children with influenza A infection: treatment with rimantadine. Pediatrics (1987) 1.80
Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. J Infect Dis (1995) 1.75
DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer. Proc Natl Acad Sci U S A (1997) 1.46
TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J Immunol (1999) 1.40
DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress. Mol Cell Biol (2008) 1.40
A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells. J Virol (1992) 1.38
Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo. Gene Ther (1998) 1.19
Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytes. J Virol (2001) 1.17
Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals. J Virol (1993) 1.05
HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. J Pharm Sci (1996) 1.05
Differential regulation of the human immunodeficiency virus type 2 enhancer in monocytes at various stages of differentiation. J Virol (1993) 1.03
RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages. Am J Physiol (1997) 0.99
The human LON protease binds to mitochondrial promoters in a single-stranded, site-specific, strand-specific manner. Biochemistry (1998) 0.96
Acquired immunodeficiency syndrome-related visceral leishmaniasis presenting in a pleural effusion. Chest (1993) 0.96
Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor. J Virol (1993) 0.94
Failure of recommended treatment for secondary syphilis. JAMA (1986) 0.94
Purification of the pets factor. A nuclear protein that binds to the inducible TG-rich element of the human immunodeficiency virus type 2 enhancer. J Biol Chem (1996) 0.94
Bacterial protease Lon is a site-specific DNA-binding protein. J Biol Chem (1997) 0.93
Angioedema presenting as chronic gastrointestinal symptoms. Am J Gastroenterol (1993) 0.92
The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells. J Virol (1995) 0.91
Overexpression of human intestinal oligopeptide transporter in mammalian cells via adenoviral transduction. Pharm Res (1998) 0.90
Bacteriophage T4 nrdA and nrdB genes, encoding ribonucleotide reductase, are expressed both separately and coordinately: characterization of the nrdB promoter. J Bacteriol (1990) 0.90
Total sequence, flanking regions, and transcripts of bacteriophage T4 nrdA gene, coding for alpha chain of ribonucleoside diphosphate reductase. J Biol Chem (1988) 0.90
Infection with HIV-2. AIDS (2001) 0.89
Factors that influence stability of recombinant adenoviral preparations for human gene therapy. Pharm Dev Technol (1998) 0.89
Bilateral renal parenchymal malacoplakia presenting as fever of unknown origin: case report and review. Clin Infect Dis (1994) 0.88
Meningococcal endocarditis presenting as cellulitis. Clin Infect Dis (1995) 0.86
Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 tat activation-response RNA decoy. J Virol (1999) 0.85
Septic arthritis caused by Neisseria sicca. J Rheumatol (1998) 0.85
Function and immunolocalization of overexpressed human intestinal H+/peptide cotransporter in adenovirus-transduced Caco-2 cells. AAPS PharmSci (1999) 0.84
Delirium associated with acyclovir treatment in a patient with renal failure. Clin Infect Dis (1995) 0.82
Osteomyelitis and intervertebral discitis caused by Pseudomonas pickettii. J Clin Microbiol (1992) 0.81
Immunologic and virologic response of HIV-2 infection to antiretroviral therapy. AIDS (1998) 0.80
The sequence and structure of the 3' arm of the first stem-loop of the human immunodeficiency virus type 2 trans-activation responsive region mediate Tat-2 transactivation. J Virol (1997) 0.78
Regulation of synthesis of ribonucleotide reductase and relationship to DNA replication in various systems. Prog Nucleic Acid Res Mol Biol (1996) 0.78
GLI-2 modulates retroviral gene expression. J Virol (2001) 0.78
Human GLI-2 is a tat activation response element-independent Tat cofactor. J Virol (2001) 0.77
Immune response with biodegradable nanospheres and alum: studies in rabbits using staphylococcal enterotoxin B-toxoid. J Microencapsul (2000) 0.76
Tandem cloning of bacteriophage T4 nrdA and nrdB genes and overproduction of ribonucleoside diphosphate reductase (alpha 2 beta 2) and a mutationally altered form (alpha 2 beta 2(93)). J Bacteriol (1992) 0.75